down arrow

Fermenta Biotec.

43
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE225B01021
  • NSEID:
  • BSEID: 506414
INR
264.05
1.65 (0.63%)
BSENSE

Apr 11, 12:46 PM

BSE+NSE Vol: 10.14 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
335.00
349.00
398.00
377.00
292.00
404.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
1.00
1.00
1.00
Net Sales
335.00
349.00
398.00
375.00
291.00
403.00
Expenditure (Ex Depriciation)
Stock Adjustments
26.00
22.00
6.00
-28.00
-27.00
-12.00
Raw Materials Consumed
104.00
131.00
146.00
163.00
106.00
105.00
Power & Fuel Cost
19.00
18.00
20.00
14.00
12.00
13.00
Employee Cost
58.00
57.00
62.00
58.00
50.00
53.00
Operating Expenses
50.00
44.00
45.00
37.00
27.00
30.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
11.00
13.00
17.00
19.00
23.00
31.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
8.00
10.00
7.00
9.00
8.00
10.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
307.00
331.00
336.00
293.00
225.00
253.00
Operating Profit (PBDIT) excl Other Income
27.00
18.00
62.00
82.00
66.00
149.00
Other Income
11.00
8.00
8.00
8.00
12.00
12.00
Operating Profit (PBDIT)
39.00
26.00
70.00
90.00
78.00
161.00
Interest
17.00
21.00
17.00
19.00
20.00
21.00
Profit before Depriciation and Tax
22.00
5.00
52.00
71.00
58.00
140.00
Depreciation
24.00
28.00
25.00
20.00
14.00
11.00
Profit Before Taxation & Exceptional Items
-2.00
-22.00
26.00
51.00
43.00
128.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-9.00
-51.00
26.00
51.00
43.00
128.00
Provision for Tax
14.00
1.00
11.00
9.00
-16.00
10.00
Profit After Tax
-24.00
-53.00
15.00
42.00
59.00
117.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
279.00
326.00
318.00
272.00
219.00
105.00
Profit Available for appropriations
256.00
275.00
333.00
318.00
279.00
222.00
Appropriations
256.00
275.00
333.00
318.00
279.00
222.00
Equity Dividend (%)
25.00%
25.00%
25.00%
50.00%
100.00%
25.00%
Earnings Per Share
-7.99
-17.70
5.35
15.77
20.63
40.72
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -4.08% vs -12.19% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 53.28% vs -70.82% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -18.47% vs 18.88% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 54.81% vs -452.79% in Mar 2023

Compare Profit and Loss Results of Fermenta Biotec.
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
335.00
10,334.00
-9,999.00
-96.76%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
335.00
10,334.00
-9,999.00
-96.76%
Expenditure (Ex Depriciation)
Stock Adjustments
26.00
-94.00
120.00
127.66%
Raw Materials Consumed
104.00
3,263.00
-3,159.00
-96.81%
Power & Fuel Cost
19.00
129.00
-110.00
-85.27%
Employee Cost
58.00
2,274.00
-2,216.00
-97.45%
Operating Expenses
50.00
210.00
-160.00
-76.19%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
11.00
928.00
-917.00
-98.81%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
8.00
134.00
-126.00
-94.03%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
307.00
7,798.00
-7,491.00
-96.06%
Operating Profit (PBDIT) excl Other Income
27.00
2,536.00
-2,509.00
-98.94%
Other Income
11.00
280.00
-269.00
-96.07%
Operating Profit (PBDIT)
39.00
2,817.00
-2,778.00
-98.62%
Interest
17.00
35.00
-18.00
-51.43%
Profit before Depriciation and Tax
22.00
2,782.00
-2,760.00
-99.21%
Depreciation
24.00
398.00
-374.00
-93.97%
Profit Before Taxation & Exceptional Items
-2.00
2,384.00
-2,386.00
-100.08%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-9.00
2,399.00
-2,408.00
-100.38%
Provision for Tax
14.00
457.00
-443.00
-96.94%
Profit After Tax
-24.00
1,926.00
-1,950.00
-101.25%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
279.00
8,012.00
-7,733.00
-96.52%
Profit Available for appropriations
256.00
9,925.00
-9,669.00
-97.42%
Appropriations
256.00
9,925.00
-9,669.00
-97.42%
Equity Dividend (%)
25%
0%
25.00
Earnings Per Share
-7.99
47.75
-55.74
-116.73%
Profit And Loss - Net Sales
Net Sales 335.66 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -4.08% vs -12.19% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 27.89 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 53.28% vs -70.82% in Mar 2023

Profit And Loss - Interest
Interest 17.43 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -18.47% vs 18.88% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax -24.01 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 54.81% vs -452.79% in Mar 2023